Skip to Main Content
Share
Help
Email
Print
Close Window
National Coverage Analysis (NCA) for Screening Immunoassay Fecal-Occult Blood Test (CAG-00180N)
Contact(s)
Jamie Hermansen
jamie.hermansen@cms.hhs.gov
410-786-2064
Back to Top
Documents
Tracking Sheet
Technology Assessment for A Comparison of the Cost-Effectiveness of Fecal Occult Blood Tests with Different Test Characteristics in the Context of Annual Screening in the Medicare Population
Decision Memo
NCD for Fecal Occult Blood Test (190.34)
NCD for Colorectal Cancer Screening Tests (210.3)
Back to Top
History of Considerations
Original Consideration for Screening Immunoassay Fecal-Occult Blood Test (this document)
Back to Top
Footer Links
Get Help with File Formats and Plug-Ins
Submit Feedback
www
